Form 4 for IMNM Immunome Inc.
Accepted 2026-08-06 18:30:38 ET · period of report 2026-08-04 · accession 0001831215-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $11.89 | +90.6K | 90.6K | New | +$1.08M |
| DT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.09 | -90.6K | 0 | -100% | -$2.27M |
| DMT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Horn Kinney | Chief BUSINESS Off | M - OptEx | $0.00 | -90.6K | 120.8K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-04 | M | A | 50,366 | $12.92 | 50,366 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-04 | M | A | 40,250 | $10.60 | 90,616 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-04 | S | D | 90,616 | $25.09 | 0 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026. (F2) The weighted average sale price for the transaction report was $25.09, and the range of prices were between $25.00 and $25.295, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-08-04 | M | D | 50,366 | $0.00 | 78,542 | D | $12.92 · — to 2034-08-08 | 50,366 Common Stock | (F3) 25% of the shares subject to the option vested on August 9, 2025, and the remaining shares will vest monthly thereafter over three years. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2026-08-04 | M | D | 40,250 | $0.00 | 120,750 | D | $10.60 · — to 2035-07-28 | 40,250 Common Stock | (F4) 25% of the shares subject to the options vested on July 29, 2026, and the remaining shares will vest monthly thereafter over three years. |